Case Study: Top 10 Pharma Company assesses PONV market size with GlobalData

Leading Pharma Company - Customer Case Study

The client, a top 10 pharma company, was preparing to launch a novel anti-emetic drug for the PONV market. Their challenge was to determine the size of the available patient population and the product's potential uptake, especially with the impending generic availability of a key competitor. They engaged GlobalData to conduct an opportunity assessment.

GlobalData implemented a solution using a chart audit process to identify the standard of care for patients. They gathered data on anti-emetic use and compared it against government surgery statistics and product sales to map the market. As a result, GlobalData identified the probable market size for the client's product and provided key recommendations for clinical and commercial steps to secure managed care coverage and optimize product uptake.